CAS

What CAS does

CAS (Chemical Abstracts Service), founded in 1907 and headquartered in Columbus, Ohio, is a non-profit division of the American Chemical Society (ACS) that curates, indexes, and commercializes the world's most comprehensive collection of scientific information. Its CAS Content Collection covers 150+ years of global scientific literature drawn from 50,000+ journals and 100+ patent authorities, including the CAS REGISTRY of 290+ million unique chemical substances assigned CAS Registry Numbers. Hundreds of in-house scientist-curators continuously index and interconnect this corpus, creating a substrate that underpins all of CAS's commercial offerings and is difficult to replicate.

CAS distributes its content through a portfolio of core platforms: the CAS SciFinder Discovery Platform (including CAS SciFinder, CAS Formulus, and CAS Analytical Methods), CAS BioFinder Discovery Platform, the STN IP Protection Suite (CAS IP Finder, FIZ PatMon, CAS Search Guard), CAS Intelligence Hub, the agentic AI system CAS Newton, and the CAS Connections integration framework. The CAS Connections framework, launched in June 2026, embeds CAS data and CAS Newton into partner R&D platforms (Albert Invent, Sapio Sciences, Inductive Bio, Scilligence, Wolfram Research) and into AI assistants (Anthropic's Claude, Microsoft Copilot) via APIs and Model Context Protocol. Specialty offerings include CAS Custom Services, CAS IP Services, CAS Registry Services, and CAS Search Services, alongside data products such as CAS Reactions, CAS References, CAS Patents, CAS Commercial Sources, CAS Formulations, and CAS Life Sciences (including CAS Biosequences).

CAS operates an enterprise-led go-to-market with multi-year subscription agreements priced per organizational scope and user count, supplemented by syndicated research reports (e.g., Microelectronics Frontiers at $5,000 individual / $8,500 enterprise licenses), API and data licensing, and project-based custom services. Customers span pharmaceutical and biotechnology multinationals (Bristol Myers Squibb, Sumitomo Dainippon Pharma, Charles River Laboratories, AMRI, ChemPartner), chemical and consumer goods majors (Dow, Syngenta, Procter & Gamble), petrochemical and materials research (PetroChina Shanghai Advanced Materials Research Institute), and academic and government institutions (MIT, Westlake University, Max Planck Society, INPI Brazil, CAPES). Distribution combines direct enterprise sales, a CAS Customer Center, an online self-service portal, the Aptean GenomeQuest reseller channel, and platform-partner/OEM integrations.

Name

CAS

Legal name

CAS (Chemical Abstracts Service), a division of the American Chemical Society

Website

https://cas.org

Company type

Private

Founded year

1907

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

CAS, a non-profit division of the American Chemical Society, curates 150+ years of global scientific literature and 290M+ chemical substances, selling subscription access via SciFinder, BioFinder, the STN IP Protection Suite, and the new CAS Newton agentic AI to pharma, biotech, chemical, and academic customers worldwide.

Ownership category

akta.pro rank

Product category

Scientific Information & R&D Software

NAICS

Other Publishers (51319), Software Publishers (5132), Libraries and Archives (51921)

SIC

Miscellaneous Publishing (2741)

akta.pro primary industry

Scientific & Laboratory Reference (Chemistry, Biology, Physics; Methods & Protocols) (EDAGAGAG)

akta.pro secondary industries

Library & Diversity Generation Platforms (display libraries, DNA-encoded libraries for biologics, variant libraries) (HLAAAIAL), Life Sciences (Biology, Ecology, Agriculture) Scholarly Publishing (EDAGAFAC)

Keywords

• Scientific information services
• Chemical substance database
• Drug discovery platforms
• Patent intelligence software
• R&D data analytics

Headquarters

HQ city

Columbus

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Enterprise Software Subscriptions: Subscription-based access to CAS solutions including SciFinder Discovery Platform, CAS BioFinder, STN IP Protection Suite, and other specialized platforms. Multi-year enterprise agreements with organizations across pharmaceutical, biotech, chemical, and academic sectors. Annual or multi-year billing based on organizational scope and user count.
2. Syndicated Reports and Market Intelligence: Sale of specialized research reports analyzing scientific trends, patent landscapes, and emerging technologies. Individual licenses at $5,000 and enterprise licenses at $8,500 for comprehensive microelectronics report. Custom analysis services available through CAS Custom Services.
3. API and Data Licensing: Machine learning and workflow integration licensing for CAS Content Collection data accessed through APIs. Deployment via Model Context Protocol and third-party AI platform integrations including Anthropic Claude and Microsoft Copilot. Revenue from technology integration partners.
4. Custom Services: CAS Custom Services providing customized solutions for unique business and R&D challenges including CAS IP Services, CAS Registry Services, and CAS Search Services. Project-based and ongoing service engagements.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels6 records

Core offering

CAS curates, indexes, and distributes the world's most comprehensive collection of scientific information through software platforms including CAS SciFinder Discovery Platform, CAS BioFinder Discovery Platform, and STN IP Protection Suite. The company provides subscription-based access to over 150 years of curated scientific literature covering 290+ million chemical substances, combined with AI-powered tools such as CAS Newton agentic AI for scientific discovery, and data licensing via APIs for enterprise R&D integration.

Product overview

CAS is a division of the American Chemical Society offering a comprehensive portfolio of scientific information solutions. The platform operates as a unified ecosystem combining core discovery platforms (CAS SciFinder Discovery Platform, CAS BioFinder Discovery Platform, STN IP Protection Suite) with specialized modules (CAS SciFinder, CAS Formulus, CAS Analytical Methods, CAS IP Finder), AI-powered solutions (CAS Newton agentic AI), and data products (CAS REGISTRY, CAS Reactions, CAS References, CAS Patents, CAS Commercial Sources, CAS Formulations, CAS Life Sciences). The CAS Connections integration framework embeds CAS data and AI capabilities directly into third-party R&D platforms. Additional offerings include custom services (CAS Custom Services, CAS IP Services, CAS Registry Services, CAS Search Services), specialized solutions (CAS Chemical Compliance Index, ChemZent, CAS Chemical Supplier Insights), and enterprise data management (CAS Intelligence Hub).

Differentiator

Problem solved

Functional benefit

Brands

• CAS Newton: Agentic AI built specifically for scientific discovery, grounded in over 150 years of curated scientific literature from the CAS Content Collection.
• CAS BioFinder
• CAS SciFinder Discovery Platform
• STN IP Protection Suite
• CAS Connections
• CAS Intelligence Hub
• CAS Custom Services
• CAS REGISTRY
• CAS Future Leaders
• CAS Innovation Incubator
• CAS Insights
• ChemZent
• CAS Common Chemistry
• CAS Chemical Safety Library

Products and services

• CAS SciFinder Discovery Platform Comprehensive scientific research discovery solution with powerful search functionality, chemical structure drawing, and advanced filtering capabilities for substances, reactions, and references for R&D organizations.
• CAS BioFinder Discovery Platform Drug discovery platform providing integrated chemistry and biological data with advanced prediction capabilities, enabling researchers to discover biological targets, uncover unconventional ligands, and identify rare biomarkers through AI-driven knowledge graphs.
• STN IP Protection Suite Comprehensive intellectual property protection suite offering patent search, analysis, and monitoring capabilities including CAS IP Finder, FIZ PatMon, and CAS Search Guard for patent professionals and IP managers.
• CAS IP Finder AI-enhanced intellectual property search solution that simplifies complex patent research with machine learning exploratory search, intuitive query builder, expanded life sciences content, and interactive visualization tools.
• CAS Newton Agentic AI system built specifically for scientific discovery that provides conversational access to 150 years of interconnected scientific knowledge from the CAS Content Collection for researchers and R&D organizations.
• CAS Connections Integration framework that embeds CAS scientific data and CAS Newton agentic AI directly into third-party R&D workflow platforms via APIs and Model Context Protocol for enterprise R&D ecosystem integration.
• CAS Intelligence Hub Cloud-based platform delivering harmonized, AI-ready datasets at enterprise scale for scientific data management transformation across organizations.
• CAS Custom Services Customized solutions for unique business and R&D challenges utilizing CAS content, technology, and expertise, including CAS IP Services, CAS Registry Services, and CAS Search Services.
• CAS REGISTRY Comprehensive registry of over 290 million unique chemical substances with authoritative CAS Registry Numbers and curated metadata for substance identification.

Quantifiable outcome

• Analysis that previously took weeks can now be completed in minutes with CAS BioFinder Discovery Platform knowledge graph
• +2 more outcomes

Named customers11 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration8 records

AI capability9 records

Feature9 records

Partnerships

22 partnerships are on record, tiered core and minor.

• Albert InventcoreTechnology or Integration · 3 June 2026Initial platform partner for CAS Connections integration framework, embedding CAS scientific data and AI capabilities into Albert Invent's R&D workflow platform for researchers.
• Sapio SciencescoreTechnology or Integration · 3 June 2026Initial platform partner for CAS Connections integration framework, integrating CAS-curated scientific knowledge and conversational AI into Sapio Sciences' research tools.
• Inductive BiocoreTechnology or Integration · 3 June 2026Initial platform partner for CAS Connections integration framework, enabling researchers to access verified scientific data within Inductive Bio's platform.
• ScilligencecoreTechnology or Integration · 3 June 2026Long-standing partner now part of CAS Connections framework, integrating CAS scientific content and AI into Scilligence R&D informatics workflows.
• Wolfram ResearchcoreTechnology or Integration · 3 June 2026Initial platform partner for CAS Connections integration framework, embedding CAS scientific knowledge and AI capabilities into Wolfram Research tools.
• Max Planck SocietycoreStrategic or Co-development Partner · 18 April 2026Joint research center launched between Max Planck and CAS in China's Shenzhen for collaborative scientific research.
• ApteancoreTechnology or Integration · 12 January 2026Expanded collaboration launching Chemical Modifications module combining Aptean GenomeQuest's search platform with CAS biosequence data, enabling biotech researchers to assess patentability of chemically modified sequences. Beta access began January 2026.
• CAPES BrazilcoreChannel Partner/ Reseller/ Distributor · 30 June 2025Expanded collaboration providing innovative CAS BioFinder life science resource to students and faculty throughout Brazil.
• Deloitte ChinacoreStrategic or Co-development Partner · 12 November 2024Strategic collaboration announced November 2024 to empower clients with market insights and scientific innovation expertise.
• PetroChina Shanghai Advanced Materials Research InstitutecoreStrategic or Co-development Partner · 17 September 2024Partnership agreement signed September 4 in Shanghai for 'Global Polymer Intelligence Research' to identify innovation hotspots and accelerate research in new chemical materials, with a report expected in 2026.
• Molecule.oneminorStrategic or Co-development Partner · 11 August 2023Strategic collaboration to accelerate drug discovery through integration of synthesis planning capabilities.
• April19minorStrategic or Co-development Partner · 17 November 2022Collaboration to accelerate real-world application of AI to discovery of novel mental health therapeutics.
• DowcoreStrategic or Co-development Partner · 24 October 2022Strategic collaboration announced October 2022 to accelerate R&D capabilities and efficiency for Dow through CAS solutions.
• INPI BrazilminorImplementation/ SI/ Consulting Partner · 22 March 2022AI-driven approach collaboration with Brazil's National Institute of Industrial Property to transform patent examinations and address application backlog.
• MITcoreStrategic or Co-development Partner · 29 October 2020Collaboration on research to enhance predictive chemical synthesis planning using CAS content and expertise.
• Pistoia AllianceminorStrategic or Co-development Partner · 19 October 2020Partnership for Chemical Safety Library powered by CAS platform to facilitate information sharing between scientists and improve laboratory safety.
• Procter & GamblecoreStrategic or Co-development Partner · 1 September 2020Multi-year enterprise agreement signed September 2020 for SciFinder access to support P&G's research operations.
• INPI BrazilminorImplementation/ SI/ Consulting Partner · 4 June 2020Technical Cooperation Agreement formalizing collaboration to tackle Brazil's patent application backlog.
• BioDurominorChannel Partner/ Reseller/ Distributor · 18 November 2019BioDuro chose SciFinder from CAS to enhance research productivity and shorten cycle times for client success.
• INPI BrazilminorImplementation/ SI/ Consulting Partner · 8 January 2019Collaboration to improve patent application examination efficiency with new AI approach.
• National Science Library, Chinese Academy of SciencesminorStrategic or Co-development Partner · 5 December 2017Joint effort resulting in Global Science & Technology Report: Graphene Research & Development whitepaper published in Chinese and English.
• WileycoreTechnology or Integration · 22 May 2017Partnership enriching Wiley's ChemPlanner technology with CAS reaction content and references, delivered exclusively in SciFinder-n. Integration of over 10 times the reaction content with new features including stereoselective retrosynthetic prediction.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Wiley: Wiley is a long-standing CAS partner (ChemPlanner integration) and also competes in scientific publishing and chemistry reference content. Both target academic, pharmaceutical, and chemical industry customers with subscription-based research tools.
• Clarivate: Clarivate provides scientific and IP intelligence including Derwent, Cortellis, and Web of Science, competing with CAS across patent search, scientific literature, and life sciences intelligence. Both serve similar enterprise customers in pharma and academia with subscription-based analytics platforms.
• Elsevier (RELX): Elsevier operates Reaxys, the closest direct competitor to CAS's chemistry and reaction databases, and Scopus for scientific literature. Both companies compete for chemistry, life sciences, and scientific information budgets at pharma, academic, and chemical industry customers.
• Springer Nature: Springer Nature publishes scientific journals, books, and databases (including Nature portfolio) and provides data analytics for life sciences and chemistry. It competes with CAS for scientific content licensing and serves overlapping academic and pharmaceutical customers.

Emerging players

• Dotmatics: Dotmatics provides scientific R&D informatics for chemistry and biology workflows, including electronic lab notebooks and data management. It competes for the same pharma/biotech R&D technology stack and partners with CAS for data integration.
• Benchling: Benchling is a cloud-native R&D platform for biotech with deep integrations to chemistry and biology data sources. It competes for lab informatics spend and is complementary with CAS for scientific data, increasingly integrating with CAS Connections.
• Insitro: Insitro is an AI-driven drug discovery company that has partnered with CAS and Bristol Myers Squibb using CAS-curated data for ALS and frontotemporal dementia research. It represents both a CAS customer/partner and a potential competitive direction for AI-native drug discovery.

Broad incumbents

• IQVIA: IQVIA is a broader life sciences intelligence incumbent serving pharma and biotech with clinical, commercial, and R&D data analytics. While less focused on chemistry data specifically, IQVIA competes for the same enterprise R&D information budget at large pharmaceutical customers.

Others

• Wolfram Research: Wolfram Research is both a CAS Connections platform partner and an adjacent player in computational and scientific knowledge engines. The partnership reflects complementary positions: CAS as the data/content layer and Wolfram as the computation/analysis layer for scientific applications.
• PubChem (NCBI/NIH): PubChem is a free, open-access chemistry database from the National Institutes of Health covering substance, compound, and bioassay data. It does not directly compete on a paid basis but provides a free alternative that pressures CAS's value proposition in the academic and basic research segments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/CASChemistry
• Facebookfacebook.com/scifinder

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CAS